ARTICLE | Company News
Eli Lilly's Xigris gets September panel date
July 23, 2001 7:00 AM UTC
The FDA's Anti-Infective Drugs Advisory Committee will review on Sept. 12 LLY's Xigris drotrecogin alfa (formerly Zovant) to treat severe sepsis. In June, the agency extended to Oct. 27 from July 27 i...